Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 60.78
-0.14 (-0.23%)
At close: Jul 18, 2025, 2:57 PM CST
Medprin Regenerative Medical Technologies Company Description
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices.
The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally.
Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is based in Guangzhou, China.
Medprin Regenerative Medical Technologies Co., Ltd.
| Country | China |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 337 |
| CEO | Jianhua Wang |
Contact Details
Address: No. 3 Yayingshi Road Guangzhou, 510700 China | |
| Website | medprin.com |
Stock Details
| Ticker Symbol | 301033 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004NB8 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jianhua Wang | GM and Director |
| Yahong Luo | Chief Financial Officer, Deputy GM and Non-Independent Director |
| Xiaoyan Long | Deputy GM, Board Secretary and Non-Independent Director |
| Yuanyuan Li | Deputy General Manager |